Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells
Ruidong Li(University of California, Riverside), Joy Y. Feng(Gilead Sciences (United States)), Xuping Xie(The University of Texas Medical Branch at Galveston), Bill J. Smith(Gilead Sciences (United States)), Raju Subramanian(Gilead Sciences (United States)), Daniel Soohoo(Gilead Sciences (United States)), Darius Babusis(Gilead Sciences (United States)), Bin Ma(Tongji University), Cynthia Kim(Gilead Sciences (United States)), Roman Sakowicz(Gilead Sciences (United States)), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston), Brian E. Schultz(Gilead Sciences (United States)), Yili Xu(Yanshan University), John P. Bilello(Global Vaccines (United States)), Jared Pitts(Gilead Sciences (United States)), Li Li(Gilead Sciences (United States)), Jingyu Zhang(East China University of Science and Technology), Jing Zou(The University of Texas Medical Branch at Galveston), Eisuke Murakami(Gilead Sciences (United States)), Congrong Niu(Gilead Sciences (United States)), Xiaofeng Zhao(Gilead Sciences (United States)), Albert Liclican(Gilead Sciences (United States)), Bernard P. Murray(Gilead Sciences (United States)), Qin Yue(Gilead Sciences (United States))
Cited by 63
Related Papers
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k